These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23012121)

  • 41. Screening based on risk for colorectal cancer is the most cost-effective approach.
    Dan YY; Chuah BY; Koh DC; Yeoh KG
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):266-71.e1-6. PubMed ID: 22100624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Necessity and feasibility of screening for colorectal cancer in China].
    Zhang SZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):16-8. PubMed ID: 21271373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy.
    Sobhani I; Alzahouri K; Ghout I; Charles DJ; Durand-Zaleski I
    Dis Colon Rectum; 2011 Jul; 54(7):876-86. PubMed ID: 21654256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An intervention to change the approach to colorectal cancer screening in primary care.
    Spruce LR; Sanford JT
    J Am Acad Nurse Pract; 2012 Apr; 24(4):167-74. PubMed ID: 22486831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination.
    Solomon MJ; McLeod RS
    CMAJ; 1994 Jun; 150(12):1961-70. PubMed ID: 7980760
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Centralised faecal blood testing for both screening and pathology requests.
    Edwards JB
    Pathology; 2010 Dec; 42(7):700-4. PubMed ID: 21080891
    [No Abstract]   [Full Text] [Related]  

  • 48. Population-based screening for colorectal cancer: Australian research and implementation.
    Young GP
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S33-42. PubMed ID: 19799696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer (Br J Surg 2009; 96: 533-540).
    Nash GF
    Br J Surg; 2009 Aug; 96(8):956-7; author reply 957. PubMed ID: 19591144
    [No Abstract]   [Full Text] [Related]  

  • 50. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence.
    Winawer S; Fletcher R; Rex D; Bond J; Burt R; Ferrucci J; Ganiats T; Levin T; Woolf S; Johnson D; Kirk L; Litin S; Simmang C;
    Gastroenterology; 2003 Feb; 124(2):544-60. PubMed ID: 12557158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Moving forward: using the experience of the CDCs' Colorectal Cancer Screening Demonstration Program to guide future colorectal cancer programming efforts.
    Seeff LC; DeGroff A; Joseph DA; Royalty J; Tangka FK; Nadel MR; Plescia M
    Cancer; 2013 Aug; 119 Suppl 15():2940-6. PubMed ID: 23868488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Strategies for expanding colorectal cancer screening at community health centers.
    Sarfaty M; Doroshenk M; Hotz J; Brooks D; Hayashi S; Davis TC; Joseph D; Stevens D; Weaver DL; Potter MB; Wender R
    CA Cancer J Clin; 2013; 63(4):221-31. PubMed ID: 23818334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lessons learned from the CDC's Colorectal Cancer Screening Demonstration Program.
    Seeff LC; Rohan EA
    Cancer; 2013 Aug; 119 Suppl 15():2817-9. PubMed ID: 23868475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design of the Polish Colonoscopy Screening Program: a randomized health services study.
    Kaminski MF; Kraszewska E; Rupinski M; Laskowska M; Wieszczy P; Regula J
    Endoscopy; 2015 Dec; 47(12):1144-50. PubMed ID: 26517847
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectiveness, training and quality assurance of colonoscopy screening for colorectal cancer.
    Robertson DJ; Kaminski MF; Bretthauer M
    Gut; 2015 Jun; 64(6):982-90. PubMed ID: 25804631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fostering partnerships and program success.
    Phillips-Angeles E; Song L; Hannon PA; Celedonia M; Stearns S; Edwards K; Feest S; Shumann A
    Cancer; 2013 Aug; 119 Suppl 15():2884-93. PubMed ID: 23868483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Colorectal cancer diagnosis improvement project evaluation demonstrates the importance of using multiple measures to track progress toward timeliness goals.
    Partin MR; Powell AA; Nugent S; Ordin DL
    J Healthc Qual; 2013; 35(3):41-8. PubMed ID: 22192595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sorting out measures and definitions of screening participation to improve comparability: the example of colorectal cancer.
    Bulliard JL; Garcia M; Blom J; Senore C; Mai V; Klabunde C
    Eur J Cancer; 2014 Jan; 50(2):434-46. PubMed ID: 24144735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Colorectal cancer control: providing adequate care to those who need it.
    Brawley OW
    J Natl Cancer Inst; 2014 Apr; 106(4):dju075. PubMed ID: 24681601
    [No Abstract]   [Full Text] [Related]  

  • 60. [Faecal occult blood test for colorectal cancer screening: high quality for a good price].
    van Veldhuizen H; Bonfrer JM; Kuipers EJ
    Ned Tijdschr Geneeskd; 2013; 157(16):A6330. PubMed ID: 23594877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.